Cargando…
Correction: SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma
Autores principales: | Li, Chiyang, Wang, Tong, Gu, Junwei, Qi, Songtao, Li, Junjie, Chen, Lei, Wu, Hang, Shi, Linyong, Song, Chong, Li, Hong, Zhu, Liwen, Lu, Yuntao, Zhou, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744844/ https://www.ncbi.nlm.nih.gov/pubmed/36509739 http://dx.doi.org/10.1038/s41419-022-05498-x |
Ejemplares similares
-
SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma
por: Li, Chiyang, et al.
Publicado: (2022) -
Correction: SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma
por: Li, Chiyang, et al.
Publicado: (2023) -
SMARCC2 combined with c-Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β-catenin signaling pathway
por: Li, Chiyang, et al.
Publicado: (2021) -
A heterotrimeric SMARCB1–SMARCC2 subcomplex is required for the assembly and tumor suppression function of the BAF chromatin-remodeling complex
por: Chen, Guidong, et al.
Publicado: (2020) -
A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
por: Song, Chong, et al.
Publicado: (2022)